Brooklyn Investment Group Makes New $41,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST)

Brooklyn Investment Group bought a new position in West Pharmaceutical Services, Inc. (NYSE:WST) in the third quarter, according to the company in its most recent disclosure with the SEC. The fund bought 136 shares of the medical instruments supplier’s stock, valued at approximately $41,000.

A number of other large investors have also added to or reduced their stakes in the stock. Ballentine Partners LLC boosted its stake in shares of West Pharmaceutical Services by 4.7% during the 2nd quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock worth $244,000 after acquiring an additional 33 shares during the last quarter. RFG Advisory LLC boosted its stake in shares of West Pharmaceutical Services by 2.3% during the 2nd quarter. RFG Advisory LLC now owns 1,499 shares of the medical instruments supplier’s stock worth $494,000 after acquiring an additional 34 shares during the last quarter. Covestor Ltd boosted its stake in shares of West Pharmaceutical Services by 14.3% during the 3rd quarter. Covestor Ltd now owns 320 shares of the medical instruments supplier’s stock worth $96,000 after acquiring an additional 40 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of West Pharmaceutical Services by 1.2% during the 3rd quarter. UMB Bank n.a. now owns 3,941 shares of the medical instruments supplier’s stock worth $1,183,000 after acquiring an additional 47 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. boosted its stake in shares of West Pharmaceutical Services by 0.4% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 12,554 shares of the medical instruments supplier’s stock worth $4,135,000 after acquiring an additional 49 shares during the last quarter. Institutional investors own 93.90% of the company’s stock.

Insider Activity at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 703 shares of West Pharmaceutical Services stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total transaction of $218,211.20. Following the transaction, the vice president now owns 1,253 shares in the company, valued at approximately $388,931.20. The trade was a 35.94 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.53% of the stock is owned by corporate insiders.

West Pharmaceutical Services Trading Up 0.7 %

Shares of West Pharmaceutical Services stock opened at $325.44 on Friday. The company’s fifty day simple moving average is $308.46 and its 200-day simple moving average is $313.41. The stock has a market capitalization of $23.57 billion, a PE ratio of 48.28, a P/E/G ratio of 24.42 and a beta of 1.00. West Pharmaceutical Services, Inc. has a 1-year low of $265.00 and a 1-year high of $413.70. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.00 and a quick ratio of 2.23.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.35. The business had revenue of $746.90 million for the quarter, compared to analysts’ expectations of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The company’s revenue was down .1% compared to the same quarter last year. During the same quarter last year, the company posted $2.16 EPS. As a group, equities analysts anticipate that West Pharmaceutical Services, Inc. will post 6.67 earnings per share for the current year.

West Pharmaceutical Services Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th were paid a dividend of $0.21 per share. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.26%. West Pharmaceutical Services’s payout ratio is 12.46%.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.